Kathleen Mullane to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Kathleen Mullane has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.197
-
Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials. Am J Nephrol. 2013; 38(1):1-11.
Score: 0.105
-
Fidaxomicin: first-in-class macrocyclic antibiotic. Expert Rev Anti Infect Ther. 2011 Jul; 9(7):767-77.
Score: 0.092